Impact of monocyte to high-density lipoprotein ratio on the identification of prevalent coronary heart disease: insights from a general population

References

• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012 Dec 15;380(9859):2095–2128.
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1;127(1):143–152.
   PubMed Web of Science ®Google Scholar
• He L, Tang X, Song Y, et al. Prevalence of cardiovascular disease and risk factors in a rural district of Beijing, China: a population-based survey of 58,308 residents. BMC Public Health. 2012 Jan 16;12:34. .
   PubMed Web of Science ®Google Scholar
• Yan R, Li W, Yin L, et al. Cardiovascular diseases and risk-factor burden in urban and rural communities in high-, middle-, and low-income regions of China: a large community-based epidemiological study. J Am Heart Assoc. 2017 Feb 6;6(2). DOI:10.1161/JAHA.116.004445.
   Web of Science ®Google Scholar
• Pepine CJ, Nichols WW. The pathophysiology of chronic ischemic heart disease. Clin Cardiol. 2007 Feb;30(2 Suppl 1):I4–9.
   PubMed Web of Science ®Google Scholar
• Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005 Jun 28;111(25):3481–3488.
   PubMed Web of Science ®Google Scholar
• Schoenhagen P, Ziada KM, Vince DG, et al. Arterial remodeling and coronary artery disease: the concept of “dilated” versus “obstructive” coronary atherosclerosis. J Am Coll Cardiol. 2001 Aug;38(2):297–306. .
   PubMed Web of Science ®Google Scholar
• Boudoulas KD, Triposciadis F, Geleris P, et al. Coronary atherosclerosis: pathophysiologic basis for diagnosis and management. Prog Cardiovasc Dis. 2016 May-Jun;58(6):676–692. .
   PubMed Web of Science ®Google Scholar
• Ardehali A, Ports TA. Myocardial oxygen supply and demand. Chest. 1990 Sep;98(3):699–705.
   PubMed Web of Science ®Google Scholar
• Bentzon JF, Otsuka F, Virmani R, et al. Mechanisms of plaque formation and rupture. Circ Res. 2014 Jun 6;114(12):1852–1866.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2045–2051.
   PubMed Web of Science ®Google Scholar
• Schaftenaar F, Frodermann V, Kuiper J, et al. Atherosclerosis. Curr Opin Lipidol. 2016;27(3):209–215. .
   PubMed Web of Science ®Google Scholar
• Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013 Jan 11;339(6116):161–166.
   PubMed Web of Science ®Google Scholar
• Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):266–274.
   PubMed Web of Science ®Google Scholar
• Rosenson RS, Brewer HB Jr., Ansell BJ, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016 Jan;13(1):48–60. .
   PubMed Web of Science ®Google Scholar
• Maiolino G, Rossitto G, Caielli P, et al. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm. 2013;2013:714653.
   PubMed Web of Science ®Google Scholar
• Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990 May 22;1044(2):275–283.
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Woollard KJ, Hoang A, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2071–2077. .
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Pagler T, Gautier EL, et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science. 2010 Jun 25;328(5986):1689–1693.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Solak Y, Unal H, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46(8):1619–1625. .
   PubMed Web of Science ®Google Scholar
• Uslu AU, Sekin Y, Tarhan G, et al. Evaluation of monocyte to high-density lipoprotein cholesterol ratio in the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 2018 Jul;24(5):828–833. .
   PubMed Web of Science ®Google Scholar
• Yilmaz S, Akboga M, Sen F, et al. Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis. Biomark Med. 2016;10(9):959–966. .
   PubMed Web of Science ®Google Scholar
• Bolayir A, Gokce S, Cigdem B, et al. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients. Neurol Neurochir Pol. 2018;52(2):150–155. .
   PubMed Web of Science ®Google Scholar
• Levey A, Stevens L, Schmid C, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. .
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. 2014 Feb 5;311(5):507–520.
   PubMed Web of Science ®Google Scholar
• Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997 Jul;20(7):1183–1197. .
   PubMed Web of Science ®Google Scholar
• Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541–553.
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998 May 12;97(18):1837–1847.
   PubMed Web of Science ®Google Scholar
• Cook NR. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction. Circulation. 2007;115(7):928–935.
   PubMed Web of Science ®Google Scholar
• Pickering JW, Endre ZH. New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol. 2012 Aug;7(8):1355–1364.
   PubMed Web of Science ®Google Scholar
• Pencina M, D’Agostino R, Steyerberg E. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11–21.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’ Agostino RB, D’ Agostino RB, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–172. .
   PubMed Web of Science ®Google Scholar
• Grunkemeier GL, Jin R. Net reclassification index: measuring the incremental value of adding a new risk factor to an existing risk model. Ann Thorac Surg. 2015 Feb;99(2):388–392.
   PubMed Web of Science ®Google Scholar
• Li Y, Li S, Ma Y, et al. Relationship between non-high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease. Coron Artery Dis. 2020 Nov;31(7):623–627. .
   PubMed Web of Science ®Google Scholar
• Akboga MK, Balci KG, Maden O, et al. Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease. Biomark Med. 2016;10(4):375–383. .
   PubMed Web of Science ®Google Scholar
• Kundi H, Gok M, Kiziltunc E, et al. Relation between monocyte to high-density lipoprotein cholesterol ratio with presence and severity of isolated coronary artery ectasia. Am J Cardiol. 2015;116(11):1685–1689. .
   PubMed Web of Science ®Google Scholar
• Cagdas M, Karakoyun S, Yesin M, et al. The association between monocyte HDL-C ratio and SYNTAX score and SYNTAX score II in STEMI patients treated with primary PCI. Acta Cardiol Sin. 2018 Jan;34(1):23–30.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li S, Guo YL, et al. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med. 2016 Aug;48(5):305–312. .
   PubMed Web of Science ®Google Scholar
• Cetin MS, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 2016 Nov;25(11):1077–1086. .
   PubMed Web of Science ®Google Scholar
• Ya G, Qiu Z, Tianrong P. Relation of monocyte/high-density lipoprotein cholesterol ratio with coronary artery disease in type 2 diabetes mellitus. Clin Lab. 2018;64(6):901–906.
   PubMed Web of Science ®Google Scholar
• Malakar AK, Choudhury D, Halder B, et al. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019 Aug;234(10):16812–16823. .
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Liu J, Ge JP, et al. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China national diabetes and metabolic disorders study. Eur Heart J. 2012 Jan;33(2):213–220. .
   PubMed Web of Science ®Google Scholar
• Ma LY, Chen WW, Gao RL, et al. China cardiovascular diseases report 2018: an updated summary. J Geriatr Cardiol. 2020 Jan;17(1):1–8.
   PubMedGoogle Scholar
• Wang Y, Li Y, Liu X, et al. Prevalence and influencing factors of coronary heart disease and stroke in Chinese rural adults: the henan rural cohort study. Front Public Health. 2019;7:411.
   PubMed Web of Science ®Google Scholar
• Chen LZ, Ding RJ, Shi QT, et al. Risk factors and prevalence of cardiovascular disease of rural residents in Xianghe of Hebei province. Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Oct;41(10):882–885.
   PubMedGoogle Scholar